COMMENT LETTER

CPR Comments on Drug Importation Proposal

CPR is concerned by the proposal to allow states and other entities to import certain prescription drugs. Importation would put American patients’ lives at risk, do little to reduce drug costs, and disincentivize pharma innovators by attacking their property rights.  

COMMENT LETTER

CPR Comments on Proposed NEPA Reform Rule

Conservatives for Property Rights (CPR), a coalition of policy organizations representing millions of Americans, strongly supports the proposed rule to update regulations implementing the procedural provisions of the National Environmental Policy Act (NEPA).  

CPR LETTER

CPR Opposition to Senate Finance Rx Bill

Many Americans share concern for the cost of medicine, particularly our country’s senior citizens.  And President Trump has rightly called out “foreign freeloaders” whose government-monopoly health systems drastically underpay for (American-developed) pharmaceuticals.  However, Senate Finance's S. 2543 proposal go about it not only in the wrong way, but in a highly destructive way.  

COALITION LETTER

Opposition to Government Medical Price Controls 

[W]hat is troubling is how often otherwise right-of-center policymakers are resorting to one of the key pillars of the Medicare for All playbook--government imposed price controls. Whether it is called price fixing, rate setting, subsidy capping, or inflation capping, government price controls have wormed their way into the healthcare reform plans of too many of our friends in Washington.  

COALITION LETTER

Ensuring U.S. 5G Leadership, Innovation, Security

In light of competition from Chinese companies that receive significant financial and political support from their government, the challenge of protecting U.S. leadership is truly a national imperative that requires a serious governmentwide approach, while working closely with private sector leaders. 

COALITION LETTER

Property Rights to Make USMCA a Trade Template

[I]mportant intellectual property protections negotiated as part of the United States- Mexico-Canada Agreement (USMCA) have been dropped from the final package. We regret that this historic opportunity to protect American innovators against intellectual property theft by foreign competitors has been lost, and we hope that this development will not become a precedent for future trade agreements.